Long‐Term miR‐669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice

BACKGROUND: Dilated cardiomyopathy (DCM) is a leading cause of chronic morbidity and mortality in muscular dystrophy (MD) patients. Current pharmacological treatments are not yet able to counteract chronic myocardial wastage, thus novel therapies are being intensely explored. MicroRNAs have been imp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Quattrocelli, Mattia, Crippa, Stefania, Montecchiani, Celeste, Camps, Jordi, Cornaglia, Antonia Icaro, Boldrin, Luisa, Morgan, Jennifer, Calligaro, Alberto, Casasco, Andrea, Orlacchio, Aldo, Gijsbers, Rik, D'Hooge, Jan, Toelen, Jaan, Janssens, Stefan, Sampaolesi, Maurilio
Formato: Artigo
Lenguaje:Inglês
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828786/
https://ncbi.nlm.nih.gov/pubmed/23963759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.113.000284
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares